Corey C. Ford

Copolymer 1 reduces relapse rate and improves disability in relapsing‐remitting multiple sclerosis

K. P. Johnson, Benjamin Brooks, J. A. Cohen et al. · Neurology · 1995 · 1.9K citations

A Baseline for the Multivariate Comparison of Resting-State Networks

Elena A. Allen, Erik B. Erhardt, Eswar Damaraju et al. · Frontiers in Systems Neuroscience · 2011 · 1.3K citations · Full text

Extended use of glatiramer acetate (Copaxone) is well tolerated and maintains its clinical effect on multiple sclerosis relapse rate and degree of disability

K. P. Johnson, Benjamin Brooks, J. A. Cohen et al. · Neurology · 1998 · 511 citations

Glatiramer Acetate Treatment, Rheumatology, Clinical Therapeutic +13

Glatiramer acetate in primary progressive multiple sclerosis: Results of a multinational, multicenter, double‐blind, placebo‐controlled trial

Jerry S. Wolinsky, Ponnada A. Narayana, Paul O’Connor et al. · Annals of Neurology · 2007 · 423 citations · Full text

The incidence and prevalence of neuropsychiatric syndromes in pediatric onset systemic lupus erythematosus.

Wilmer L. Sibbitt, John R. Brandt, Courtney R. Johnson et al. · PubMed · 2002 · 330 citations